Rheumor Has It podcast

CAR-T: Not Your Average Infusion

2026-10-29
0:00
17:36
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

Your patient saw CAR-T on their social media feed and wants to know if it could help them. Where do you start?

Host Sheila Behimehr, NP talks with Leila Khalili, NP, a rheumatology nurse practitioner and Director of Clinical Research Operations at Hospital for Special Surgery. They cover what CAR-T cells are, why they're called "living drugs," and how a cancer therapy found its way into rheumatology.

You'll also get the full patient journey, from screening to infusion, plus the risks nurses need to know: infection, cytokine release syndrome, and neurotoxicity.

The big takeaway: CAR-T is a journey, not a single appointment. Talk about it early.

Part one of three. Next up: what the data says so far.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

Fler avsnitt från "Rheumor Has It"